Later-born siblings of children with autism spectrum disorder (ASD) or attention-deficit/hyperactivity disorder (ADHD) are at elevated risk for both disorders, a new study led by Meghan Miller, assistant professor in the ...
Dec 10, 2018
0
13
Autism Speaks, the world's largest autism science and advocacy organization, joined in announcing significant findings from the largest known study of younger siblings of children who had a verified diagnosis of autism spectrum ...
Aug 15, 2011
0
0
Early-stage breast cancer patients whose tumors carry genetic markers associated with a low risk of disease recurrence may not need to undergo chemotherapy, suggests a new study that employed a test devised by a UC San Francisco ...
Aug 25, 2016
0
79
For patients undergoing surgery to repair a bunion deformity of the foot, non-weight-bearing x rays taken immediately after surgery can provide a good estimate of the risk that the bunion will return over time, reports a ...
Jul 24, 2017
0
2
A new editorial paper was published in Oncoscience and is titled "HER2 expression should be routinely evaluated in DCIS to avoid under or overtreatment!"
Feb 17, 2023
0
19
A team of researchers from the City of Hope in Duarte, Calif., has developed a speedy way to identify drugs and chemicals that can disrupt the balance of sex hormones in human beings and influence the development and progress ...
Feb 21, 2014
0
1
A new study from Uppsala University shows that many patients with colon cancer do not need any chemotherapy and that among patients who benefit from chemotherapy it does not have to be as intense for everyone.
Aug 30, 2018
0
0
(HealthDay)—For patients with melanoma, use of propranolol is associated with reduced risk of recurrence, according to a study published online Sept. 28 in JAMA Oncology.
Sep 29, 2017
1
31
Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation to treat the abnormal heart rhythm lower their long-term risk of a recurrent stroke by 50 percent, according to new research from the ...
Nov 13, 2016
0
3
In a new study from Kaiser Permanente, researchers found the use of aromatase inhibitors, hormone-therapy drugs used to treat patients with breast cancer, was not associated with an increased risk of fatal cardiovascular ...
Apr 21, 2016
0
2
